Compass Minerals International earnings date
Compass Minerals International (CM8) Q3 2026 Earnings Report
DE:CM8 Q3 2026 EPS Results
- Actual EPS
- -EUR 0.13
- Consensus EPS
- -EUR 0.06
- Beat/Miss
- Missed by -EUR 0.07
- One Year Ago EPS
- -EUR 0.35
DE:CM8 Q3 2026 Revenue Results
- Actual Revenue
- EUR 195.33M
- Expected Revenue
- EUR 188.48M
- Beat/Miss
- Beat by +EUR 6.85M
- YoY Revenue Growth
- +0.33%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 08/05/2026
- Time
- After Close
- Conference Call
- Wednesday, August 5, 2026
Compass Minerals International's next earnings date is estimated for November 23, 2026, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call presented a mix of meaningful operational and financial progress alongside ongoing operational challenges. Notable positives include a strong turnaround at Plant Nutrition (Ogden) with material margin and EBITDA improvement, constructive salt pricing in the bid season, an upward revision to consolidated EBITDA guidance, a strengthened balance sheet with reduced net leverage and an S&P upgrade, and active capital/operational initiatives (dryer project, maintenance, accelerator teams). Offsetting these gains are near-term execution issues in mining operations—particularly at Goderich—leading to higher per-unit production and logistics costs, a quarter-over-quarter decline in Salt EBITDA and operating earnings, lower highway volumes, and slower-than-expected realization of efficiency gains (resulting in delayed project timing and short-term cash flow pressures). Overall, the positives (guidance raise, Plant Nutrition outperformance, pricing momentum, and balance sheet repair) appear to outweigh the lowlights, though the company must convert operational initiatives into sustained cost declines to deliver on the optimism expressed.
Compass updated FY‑2026 guidance, raising consolidated adjusted EBITDA midpoint to $230 million (range $218–$242M), raising Plant Nutrition segment adjusted‑EBITDA to $49–$57M (from $43–$47M), and narrowing Salt adjusted‑EBITDA to $225–$236M (previously $225–$240M); corporate & other costs are guided at $51–$56M and full‑year capital expenditures at $90–$110M. Management said it will provide tighter FY‑2027 and winter volume/price guidance in Q4 and will disclose fuel sensitivity then, while continuing Ogden investments (dryer project to complete by end of next fiscal year) and prioritizing disciplined capital deployment and debt reduction after improving net leverage to ~2.8x (from 4.3x), reducing total debt to $716.6M (net debt $660.3M), and maintaining total liquidity of $328.1M (cash $56.3M, revolver $271.8M).
- Plant Nutrition (Ogden) Strong Operational RecoveryOgden produced segment-adjusted EBITDA of $15.0M in the quarter (up 32% from $11.4M prior year), operating earnings of $7.8M (up 50% from $5.2M), and per-unit product and distribution costs declined year-over-year. Full-year Plant Nutrition guidance raised to $49M–$57M (from $43M–$47M). Investment underway (dryer project) expected to improve yield and product quality by end of next fiscal year.
- Salt Pricing Improvement and Constructive Bid SeasonSalt segment pricing up 9% overall (highway pricing +8%, C&I +6%) and management cites double-digit price improvements in some core U.S. highway markets during the '26–'27 bid season. Management reports structurally tight North American highway de-icing markets and low industry inventories supporting pricing and larger tenders.
- Raised Consolidated Adjusted EBITDA GuidanceConsolidated adjusted EBITDA midpoint raised to $230M with a range of $218M–$242M, reflecting stronger Plant Nutrition and constructive salt pricing despite operational headwinds.
- Balance Sheet Improvement and Credit UpgradeNet leverage improved to 2.8x from 4.3x a year ago. Total net debt down ~13% YoY (net debt $660.3M, down $85.6M YoY) and total debt $716.6M (from $825.3M). Company received a recent S&P credit upgrade, and total liquidity of $328.1M (cash $56.3M + $271.8M revolver).
- Operational and Capital DisciplineCapital expenditures YTD $62.1M (vs $53.8M prior year); full-year capex guidance $90M–$110M. Management emphasizing investment in assets, preventative maintenance, accelerator teams, network optimization, procurement, and disciplined capital allocation including continued debt reduction.
- Plant Nutrition Unit Economics and Yield InitiativesExcluding Wynyard divestiture impacts, Plant Nutrition sales volumes increased ~4% year-over-year and average sales price increased ~4%. Management plans to capture additional yield via the dryer/compaction project to reduce yield loss and improve per-ton economics starting around next year.
- Commercial Protections and Tariff MitigationCompany implemented pass-through provisions and contract terms to meaningfully reduce exposure to impending Canada-to-U.S. tariffs (effective Aug 19). Management states they are better positioned than a year ago to manage tariff and fuel volatility risks.
DE:CM8 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 23, 2026 | 2026 (Q4) | -0.05- | -0.15 | ― | ― |
| Aug 05, 2026 | 2026 (Q3) | -0.06-0.13 | -0.35 | 64.10% (+0.23) | |
| May 06, 2026 | 2026 (Q2) | 0.540.57 | 0.57 | 0.00% (+0.00) | |
| Feb 04, 2026 | 2026 (Q1) | 0.230.39 | -0.5 | 178.18% (+0.89) | |
| Dec 08, 2025 | 2025 (Q4) | -0.21-0.15 | -0.7 | 77.92% (+0.54) | |
| Aug 11, 2025 | 2025 (Q3) | -0.05-0.35 | -0.92 | 61.39% (+0.56) | |
| May 07, 2025 | 2025 (Q2) | 0.000.57 | 1.35 | -57.72% (-0.78) | |
| Feb 10, 2025 | 2025 (Q1) | 0.12-0.50 | 0.05 | -1200.00% (-0.54) | |
| Dec 16, 2024 | 2024 (Q4) | ―- | -0.05 | ― | |
| Oct 30, 2024 | 2024 (Q3) | -0.44-0.70 | -0.05 | -1183.33% (-0.64) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


